Journal of the American Chemical Society
ARTICLE
Gu, X.-P.; Okuhara, T.; Okahara, M. Synthesis 1990, 32. (e) Nowicki, A.;
Mortreux, A.; Agbossou-Niedercorn, F. Tetrahedron Lett. 2005, 46,
1617. Benzyl carbonyls (nucleophile stabilized by carbonyl group):
(f) Suzuki, O.; Hashiguchi, Y.; Inoue, S.; Sato, K. Chem. Lett. 1988, 291.
(g) Suzuki, O.; Inoue, S.; Sato, K. Bull. Chem. Soc. Jpn. 1989, 62, 239.
(h) Gravel, D.; Benoit, S.; Kumanovic, S.; Sivaramakrishnan, H. Tetra-
hedron Lett. 1992, 33, 1407. (i) Gravel, D.; Benoit, S.; Kumanovic, S.;
Sivaramakrishnan, H. Tetrahedron Lett. 1992, 33, 1403. (j) Trost, B. M.;
Schroeder, G. M.; Kristensen, J. Angew. Chem., Int. Ed. 2002, 41, 3492.
(k) Yan, X.-X.; Liang, C.-G.; Zhang, Y.; Hong, W.; Cao, B.-X.; Dai, L.-X.;
Hou, X.-L. Angew. Chem., Int. Ed. 2005, 44, 6544. (l) Lebeuf, R.; Hirano,
K.; Glorius, F. Org. Lett. 2008, 10, 4243. (m) Trost, B. M.; Xu, J.;
Schmidt, T. J. Am. Chem. Soc. 2009, 131, 18343. (n) Zhao, Y.; Zhou, Y.;
Liang, L.; Yang, X.; Du, F.; Li, A.; Zhang, H. Org. Lett. 2009, 11, 555. p-
Nitrotoluenes:(o) Waetzig, S. R.; Tunge, J. A. J. Am. Chem. Soc. 2007,
129, 14860. (p) Kim, I. S.; Ngai, M.-Y.; Krische, M. J. J. Am. Chem. Soc.
2008, 130, 6340.
(8) Non-metal-catalyzed allylation of toluene derivatives (three
examples) with several allyl bromides via radical process (yield average:
61%): (a) Tanko, J. M.; Sadeghipour, M. Angew. Chem., Int. Ed. 1999,
38, 159. (b) Struss, J. A.; Sadeghipour, M.; Tanko, J. M. Tetrahedron Lett.
2009, 50, 2119.
(9) Non-metal-catalyzed allylation of toluene derivatives with allyl
bromide via arene η6-coordination to organometallic fragment. Fe:
(a) Moulines, F.; Astruc, D. J. Chem. Soc., Chem. Commun. 1989, 614.
(b) Martinez, V.; Blais, J.-C.; Astruc, D. Org. Lett. 2002, 4, 651. (c) Martinez,
V.; Blais, J.-C.; Astruc, D. Angew. Chem., Int. Ed. 2003, 42, 4366. Cr:(d) Hata,
T.; Koide, H.; Taniguchi, N.; Uemura, M. Org. Lett. 2000, 2, 1907. Ru:
(e) Pigge, F. C.; Fang, S.; Rath, N. P. Tetrahedron Lett. 1999, 40, 2251.
(10) Ono Pharmaceutical Co., Ltd. Preventive and/or Remedy for
Hyperkalemia Containing EP4 Agonist. Eur. Patent 1782829 (A1), 2007.
(11) MerrellPharmaceuticals, Inc. Useof (E)-2-(p-Fluorophenethyl)-3-
Fluoroallylamine in the Treatment of Alzheimer’s Disease. Eur. Patent
0642338 (B1), 1997.
(12) Ono Pharmaceutical Co., Ltd. Preventive and/or Remedy for
Lower Urinary Tract Diseases Containing EP4 Agonist. Eur. Patent
1782830 (A1), 2007.
(13) (a) Unilever Home and Personal Care USA, Division of
Conopco, Inc. Cosmetic Compositions Containing Sophora Alopecur-
oides L. Extracts. US Patent 2006/110341 (A1), 2006. (b) Gupta, S. K.
New Ubiquitin-Proteasome Regulating Compounds and Their Applica-
tion in Cosmetic and Pharmaceutical Formulations. US Patent 2006/
269494 (A1), 2006.
(14) (a) Kouznetsov, V.; Urbina, J.; Palma, A.; Lopez, S.; Devia, C.;
Enriz, R.; Zacchino, S. Molecules 2000, 5, 428. (b) Vargas, L. Y.; Castelli,
M. V.; Kouznetsov, V. V.; Urbina, J. M.; Lopez, S. N.; Sortino, M.; Enriz,
R. D.; Ribas, J. C.; Zacchino, S. Bioorg. Med. Chem. 2003, 11, 1531.
(c) Gomez-Barrio, A.; Montero-Pereira, D.; Nogal-Ruiz, J. J.; Escario,
J. A.; Muelas-Serrano, S.; Kouznetsov, V. V.; Mendez, L. Y. V.; Gonzalez,
J. M. U.; Ochoa, C. Acta Parasitol. 2006, 51, 73.
Cherepanov, I. A.; Moiseev, S. K. Metalloorg. Khim. 1991, 4, 177.
Organomet. Chem. USSR 1991, 4, 94. (h) Kalinin, V. N.; Cherepanov,
I. A.; Moiseev, S. K. J. Organomet. Chem. 1997, 536ꢀ537, 437. Density
functional theory calculations:(i) Merlic, C. A.; Walsh, J. C.; Tantillo,
D. J.; Houk, K. N. J. Am. Chem. Soc. 1999, 121, 3596. (j) Merlic, C. A.;
Miller, M. M.; Hietbrink, B. N.; Houk, K. N. J. Am. Chem. Soc. 2001,
123, 4904. (k) Merlic, C. A.; Hietbrink, B. N.; Houk, K. N. J. Org. Chem.
2001, 66, 6738.
(17) Uemura, M. Organic Reactions: Wiley: New York, 2006; Vol. 67,
p 217.
(18) When 1H NMR deprotonation studies were conducted in THF
with 1 equiv each of 1l and LiN(SiMe3)2, 1l exhibited approximately
50% deprotonation. Under similar conditions, 1a exhibited 10%
deprotonation. See McGrew, G. I.; Temaismithi, J.; Carroll, P. J.; Walsh,
P. J. Angew. Chem., Int. Ed. 2010, 49, 5541.
(19) Early reports on palladiumꢀtriphenylphosphine-catalyzed
allylic substitution reactions: (a) Atkins, K. E.; Walker, W. E.; Manyik,
R. M. Tetrahedron Lett. 1970, 3821. (b) Hata, G.; Takahashi, K.; Miyake,
A. J. Chem. Soc., Chem. Comm. 1970, 1392. (c) Trost, B. M.; Fullerton,
T. J. J. Am. Chem. Soc. 1973, 95, 292. Recent report by our group:
(d) Hussain, M. M.; Walsh, P. J. Angew. Chem., Int. Ed. 2010, 49, 1834.
(20) (a) Dreher, S. D.; Dormer, P. G.; Sandrock, D. L.; Molander,
G. A. J. Am. Chem. Soc. 2008, 130, 9257. (b) Dreher, S. D.; Lim, S.-E.;
Sandrock, D. L.;Molander, G. A.J. Org. Chem. 2009, 74, 3626. (c) Sandrock,
D. L.; Jean-Gerard, L.; Chen, C.-Y.; Dreher, S. D.; Molander, G. A. J. Am.
Chem. Soc. 2010, 132, 17108. (d) Molander, G. A.; Argintaru, O. A.;
Aron, I.; Dreher, S. D. Org. Lett. 2010, 12, 5783. (e) Molander, G. A.;
Trice, S. L. J.; Dreher, S. D. J. Am. Chem. Soc. 2010, 132, 17701.
(21) (a) Gossage, R. A.; Jastrzebski, J. T. B. H.; van Koten, G. Angew.
Chem., Int. Ed. 2005, 44, 1448. (b) Jones, A. C.; Sanders, A. W.; Bevan,
M. J.; Reich, H. J. J. Am. Chem. Soc. 2007, 129, 3492. (c) Gessner, V. H.;
Daschlein, C.; Strohmann, C. Chem.ꢀEur. J. 2009, 15, 3320.
(22) (a) Traylor, T. G.; Stewart, K. J.; Goldberg, M. J. J. Am. Chem.
Soc. 1984, 106, 4445. (b) Traylor, T. G.; Stewart, K. J. J. Am. Chem. Soc.
1986, 108, 6977. (c) Traylor, T. G.; Goldberg, M. J. J. Am. Chem. Soc.
1987, 109, 3968.
(23) Early reports on Pd-catalyzed cross-coupling of (η6-
chloroarene)Cr(CO)3 compounds: (a) Villemin, D.; Schigeko, E.
J. Organomet. Chem. 1985, 293, C10. (b) Carpentier, J. F.; Castanet, Y.;
Brocard, J.; Mortreux, A.; Petit, F. Tetrahedron Lett. 1991, 32, 4705.
(c) Carpentier, J. F.; Castanet, Y.; Brocard, J.; Mortreux, A.; Petit, F.
Tetrahedron Lett. 1992, 33, 2001. (d) Uemura, M.; Nishimura, H.;
Hayashi, T. Tetrahedron Lett. 1993, 34, 107. (e) Uemura, M.; Nishimura,
H.; Kamikawa, K.; Nakayama, K.; Hayashi, Y. Tetrahedron Lett. 1994,
35, 1909. (f) Uemura, M.; Nishimura, H.; Hayashi, T. J. Organomet.
Chem. 1994, 473, 129. (g) Carpentier, J. F.; Finet, E.; Castanet, Y.;
Brocard, J.; Mortreux, A. Tetrahedron Lett. 1994, 35, 4995.
(24) (a) You, S.-L.; Zhu, X.-Z.; Luo, Y.-M.; Hou, X.-L.; Dai, L.-X.
J. Am. Chem. Soc. 2001, 123, 7471. (b) Pretot, R.; Pfaltz, A. Angew. Chem.,
Int. Ed. 1998, 37, 323.
(25) (a) Trost, B. M.; Toste, F. D. J. Am. Chem. Soc. 1999, 121, 4545.
(b) Butts, C. P.; Filali, E.; Lloyd-Jones, G. C.; Norrby, P.-O.; Sale, D. A.;
Schramm, Y. J. Am. Chem. Soc. 2009, 131, 9945.
(26) (a) Bravo-Altamirano, K.; Montchamp, J.-L. Org. Lett. 2006,
8, 4169. (b) Usui, I.; Schmidt, S.; Breit, B. Org. Lett. 2009, 11, 1453. In
these papers, only linear products were reported without mentioning
branched products.
(27) (a) Cavallini, G.; Massarani, E.; Nardi, D.; Mauri, L.; Barzaghi,
F.; Mantegazza, P. J. Am. Chem. Soc. 1959, 81, 2564. (b) Attwood, D.
J. Pharm. Pharmacol. 1976, 28, 407. (c) Tobe, A.; Yoshida, Y.; Ikoma, H.;
Tonomura, S.; Kikumoto, R. Arzneim. Forsch., Drug. Res. 1981,
31ꢀ2, 1278. (d) Ohizumi, Y.; Takahashi, M.; Tobe, A. Br. J. Pharmacol.
1982, 75, 377. (e) Hattori, H.; Yamamoto, S.; Iwata, M.; Takashima, E.;
Yamada, T.; Suzuki, O. J. Chromatogr.-Biomed. 1992, 581, 213. (f) Li, J. J.;
Johnson, D. S.; Sliskovic, D. R.; Roth, B. D. Contemporary Drug Synthesis;
Wiley-Interscience: 2004; p 221 (Zyrtec).
(15) (a) Kang, T. H.; Jeong, S. J.; Ko, W. G.; Kim, N. Y.; Lee, B. H.;
Inagaki, M.; Miyamoto, T.; Higuchi, R.; Kim, Y. C. J. Nat. Prod. 2000,
63, 680. (b) Chi, Y. S.; Jong, H. G.; Son, K. H.; Chang, H. W.; Kang, S. S.;
Kim, H. P. Biochem. Pharmacol. 2001, 62, 1185. (c) Sohn, H. Y.; Son,
K. H.; Kwon, C. S.; Kwon, G. S.; Kang, S. S. Phytomedicine 2004, 11, 666.
(16) For books: (a) K€undig, E. P. Transition Metal Arene
π-Complexes in Organic Synthesis and Catalysis. Topics in Organome-
tallic Chemistry, 7; Springer-Verlag: Berlin, Heidelberg, NY, 2004.
(b) Hartwig, J. F. Organotransition Metal Chemistry: From Bonding to
Catalysis; University Science Books: Sausalito, CA, 2010. For reviews:
(c) Kalinin, V. N. Usp. Khim. 1987, 56, 1190. Russ. Chem. Rev. 1987,
56, 682. (d) Rosillo, M.; Dominguez, G.; Perez-Castells, J. Chem. Soc.
Rev. 2007, 36, 1589. For recent reports on asymmetric benzylic
deprotonation of (η6-arene)Cr(CO)3(e) Koide, H.; Hata, T.; Uemura,
M. J. Org. Chem. 2002, 67, 1929, and references therein. (f) Castaldi,
M. P.; Gibson, S. E.; Rudd, M.; White, A. J. P. Chem.ꢀEur. J. 2006, 12,
138, and references therein. For early reports on benzylic deprotona-
tion of (η6-arene)Cr(CO)3 under mild conditions: (g) Kalinin, V. N.;
(28) (a) Oster, G.; Nishijima, Y. J. Am. Chem. Soc. 1956, 78, 1581.
(b) Bomberger, D. C.; Gwinn, J. E.; Boughton, R. L. Wastes from
20559
dx.doi.org/10.1021/ja208935u |J. Am. Chem. Soc. 2011, 133, 20552–20560